Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05537298 · ClinicalTrials.gov registry record
Muscle Recovery After Critical Illness
A clinical trial of Critical Illness and Muscle Weakness, sponsored by Kirby Mayer.
- Recruiting
- Registry status
- 209
- Enrollment target
- 3
- Study locations
NCT05537298: Recruiting study of Critical Illness and Muscle Weakness, sponsored by Kirby Mayer.
NCT05537298 is a study of Critical Illness and Muscle Weakness that is actively recruiting participants, run by Kirby Mayer. The registered enrollment target is 209 participants, below the 3,136-participant average among 91 other Critical Illness trials with a reported enrollment target (93% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05537298, a study of Critical Illness and Muscle Weakness, is actively recruiting participants, sponsored by Kirby Mayer.
- RECRUITING
- Registry status
- 209 participants
- Enrollment target
- 3
- Study locations
Study Summary
The overarching goal of the proposed study is to determine the trajectories of physical recovery and cellular markers involved with the underlying failure to recover muscle after critical illness, while exploring which characteristics are associated with sustained physical disability. This proposal will examine muscle pathophysiology carefully aligned with physical function outcomes in order to longitudinally assess the recovery, or failed recovery, of muscle function in participants after critical illness: 1. to examine the recovery of muscle and physical function in ICU survivors through longitudinal assessments 2. to investigate the underlying cellular markers and mechanisms of muscle recovery in ICU survivors 3. to determine which cellular markers contribute to physical disability in ICU survivors up to 1 year after hospital admission
Primary Outcome
Short Physical Performance Battery
Conditions Studied
Study Locations (3)
Alabama
- University of Alabama at Birmingham - Birmingham
Kentucky
- University of Kentucky - Lexington
Oklahoma
- Oklahoma Medical Research Foundation - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2022-10-18 |
| Est. Completion | 2027-08-01 |
What NCT05537298 shows while recruiting
NCT05537298 is an observational study that tracks outcomes without assigning an intervention. The registered 209 participants enrollment target is mid-sized for trials with a published cap, below the 3,136-participant average among 91 other Critical Illness trials with a reported enrollment target (93% lower).
The record links to 4 conditions, with Critical Illness appearing as the primary indexed condition, and to 0 interventions.
NCT05537298 reports a single indexed study location in Alabama, Kentucky, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT05537298 about?
NCT05537298 is a clinical study titled "Muscle Recovery After Critical Illness". The overarching goal of the proposed study is to determine the trajectories of physical recovery and cellular markers involved with the underlying failure to recover muscle after critical illness, while exploring which characteristics are associated with sustained physical disability. This proposal ...
What is the current status of trial NCT05537298?
This trial is currently recruiting. The enrollment target is 209 participants. The study started on 2022-10-18. Estimated completion is 2027-08-01.
What conditions does trial NCT05537298 study?
This clinical trial studies the following conditions: Critical Illness, Muscle Weakness, ICU Acquired Weakness, Post Intensive Care Unit Syndrome.
Who is sponsoring clinical trial NCT05537298?
This trial is sponsored by Kirby Mayer, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05537298 being conducted?
This trial has 3 study locations across Alabama, Kentucky, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05537298's enrollment target sits among peer trials
209 48th of 91 higher than 43 of 91 other Critical Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
RECRUITING
-
Improving Needs Among Older Adults
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
Safety and Feasibility of a Self-Balancing Exoskeleton for Rehabilitation in the Thoracic Surgical Intensive Care Unit: a Pilot Trial
RECRUITING · Phase 1
-
12-hour Time Limited Feeding in Critical Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04742634 · 209 participants · Phase 1
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
- NCT07214688 · 209 participants · Phase 2
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI